Quick Answer
MBX Biosciences, Inc. reported Total Assets of $385.14 million for the year ending 2025.
- MBX Biosciences, Inc. showed an increase of +43.4% in Total Assets from 2024 to 2025.
- This data is from MBX Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2024: $282.40 million | Q1 2025: $245.93 million | Q2 2025: $231.52 million | Q3 2025: $400.08 million.
- Over the full 3 years of available data (2023 to 2025), MBX Biosciences, Inc.'s Total Assets has grown by 357.5%.
- Historical annual values: Fiscal year 2025: $385.14 million | Fiscal year 2024: $268.54 million | Fiscal year 2023: $84.18 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: